Navigation Links
Improving The Survival Of Lung Cancer Patients By Blocking The Effects Of Estrogen

Stopping or slowing the spread of lung cancer may depend on the addition of drugs that block the effects of estrogen, // say researchers according to a recent study .

For the study researchers evaluated the effects of three different treatments that block the action of estrogen in human lung tumors grafted in mice. They studied the effectiveness of an estrogen receptor-blocking drug (fulvestrant, also known as Faslodex), an epidermal growth factor receptor-blocking drug (gefitinib, also known as Iressa), and a combination of both drugs.

Results showed combining both drugs was most effective at shrinking the tumors, with a 59-percent decrease in tumor volume compared to a 49-percent decrease using gefitinib alone and a 32-percent decrease using fulvestrant alone.

In another study done researchers found estrogen regulated some of the same growth genes in lung cancer as in breast cancer and results showed that the same estrogen inhibitor from the first study, fulvestrant, also blocked estrogen's ability to regulate lung cancer cell gene expression.

Thus researchers say both of these studies clearly suggest that lung cancer cells respond to estrogen and that improving overall patient survival may be contingent upon identifying therapies that target specific pathways and put a halt to estrogen signaling.
'"/>




Page: 1

Related medicine news :

1. Plastic Sling Has Proved Successful In Improving Aging Of The Neck
2. Improving Survival Rate Of Lung Cancer Patients
3. Combination Therapy Effective In Improving Lung Cancer Survival
4. Improving Life Expectancy
5. Improving Fertility In Patients With Cervical Cancer
6. Improving Lighting Could Bring About A Change In Alzheimers Patients
7. Device For Improving Bone Mass In Osteoporosis
8. Olive Oil Found To Preserve Cardiovascular Health by Improving Function
9. US To Look In To Improving the Elder Care
10. Saw Palmetto Extract No Good In Improving Prostate Health
11. Rahul Mahajans Condition Improving; Vital Parametres Normal
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: